Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$530K Sell
15,217
-513
-3% -$18K 2.66% 13
2020
Q2
$488K Sell
15,730
-3,760
-19% -$128K 2.49% 17
2020
Q1
$604K Sell
19,490
-9,071
-32% -$309K 2.87% 13
2019
Q4
$1.06M Buy
+28,561
New +$1.02M 1.67% 27

Other funds holding PFE

AMG Funds's PFE Position: Q3 2020 in Review

AMG Funds reduced its Pfizer (PFE) stake by 3.3% in Q3 2020, selling an estimated $18K and leaving 15,217 shares worth $530K. The position accounts for 2.66% of the portfolio, ranked #13.

AMG Funds first reported a position in PFE in Q4 2019 and has held it in 4 quarters since. The position peaked at $1.06M in Q4 2019. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • AMG Funds held 15,217 shares of Pfizer worth $530K as of Q3 2020.
  • AMG Funds sold 513 Pfizer shares in Q3 2020, an estimated $18K.
  • Pfizer made up 2.66% of AMG Funds's portfolio in Q3 2020, its #13 holding.
  • AMG Funds first reported a position in Pfizer in Q4 2019 and has held it in 4 quarters since.
  • AMG Funds's Pfizer position peaked at $1.06M in Q4 2019.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on AMG Funds's 13F filing for Q3 2020, filed 12 Nov 2020.